‘TumorPrint’ project for the printing of human cancer models receives EU funding
CELLINK (Gothenburg, Sweden) have been awarded a €2.5 million grant from the European Commission to develop and commercialize their project, ‘TumorPrint’, for the benefit of research into cancer tumors and their cellular reactions to different pharmaceutical compounds.
Please sign in or register for FREE
Sign in to 3DMedNet
Not a member yet? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Journal of 3D Printing in Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Sign up now!
Did you know?
Your 3DMedNet account also gives you access to communities on regenerative medicine, real-world evidence and drug discovery. Find out more>>
No comments yet.